Elena Gallardo

2.0k total citations
42 papers, 1.3k citations indexed

About

Elena Gallardo is a scholar working on Cellular and Molecular Neuroscience, Neurology and Oncology. According to data from OpenAlex, Elena Gallardo has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 15 papers in Neurology and 9 papers in Oncology. Recurrent topics in Elena Gallardo's work include Hereditary Neurological Disorders (16 papers), Peripheral Neuropathies and Disorders (9 papers) and Genetic Neurodegenerative Diseases (8 papers). Elena Gallardo is often cited by papers focused on Hereditary Neurological Disorders (16 papers), Peripheral Neuropathies and Disorders (9 papers) and Genetic Neurodegenerative Diseases (8 papers). Elena Gallardo collaborates with scholars based in Spain, Belgium and United States. Elena Gallardo's co-authors include Antonio Garcı́a, José Berciano, Onofre Combarros, Tania Díaz, Núria Viñolas, Neil G. Simon, Ramón M. Marrades, Angels Quera, Eva Bandrés and Bernat Gel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Brain.

In The Last Decade

Elena Gallardo

41 papers receiving 1.3k citations

Peers

Elena Gallardo
Elena Gallardo
Citations per year, relative to Elena Gallardo Elena Gallardo (= 1×) peers Yuanyuan Du

Countries citing papers authored by Elena Gallardo

Since Specialization
Citations

This map shows the geographic impact of Elena Gallardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Gallardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Gallardo more than expected).

Fields of papers citing papers by Elena Gallardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Gallardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Gallardo. The network helps show where Elena Gallardo may publish in the future.

Co-authorship network of co-authors of Elena Gallardo

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Gallardo. A scholar is included among the top collaborators of Elena Gallardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Gallardo. Elena Gallardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuente, María de la, et al.. (2025). Primary lymphoma arising in Paget’s disease in a patient with primary hyperparathyroidism. European Journal of Case Reports in Internal Medicine. 12(2). 4778–4778.
2.
Sivera, Rafael, Ana L. Pelayo‐Negro, Ivonne Jericó, et al.. (2024). Expanding the Clinical Spectrum of DRP2 -Associated Charcot-Marie-Tooth Disease. Neurology. 102(7). e209174–e209174. 2 indexed citations
3.
Berciano, José, Pedro Orizaola, Elena Gallardo, et al.. (2019). Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study. Clinical Neurophysiology Practice. 5. 1–9. 19 indexed citations
4.
Berciano, José, Antonio Garcı́a, Elena Gallardo, et al.. (2017). Intermediate Charcot–Marie–Tooth disease: an electrophysiological reappraisal and systematic review. Journal of Neurology. 264(8). 1655–1677. 67 indexed citations
5.
Gallardo, Elena, Beatriz Sarriá, J.P. De La Cruz, et al.. (2016). Synthesis and Antioxidant Activity of Alkyl Nitroderivatives of Hydroxytyrosol. Molecules. 21(5). 656–656. 22 indexed citations
6.
Berciano, José, María J. Sedano, Ana L. Pelayo‐Negro, et al.. (2016). Proximal nerve lesions in early Guillain–Barré syndrome: implications for pathogenesis and disease classification. Journal of Neurology. 264(2). 221–236. 53 indexed citations
7.
Berciano, José, Koen Peeters, Antonio Garcı́a, et al.. (2015). NEFL N98S mutation: another cause of dominant intermediate Charcot–Marie–Tooth disease with heterogeneous early-onset phenotype. Journal of Neurology. 263(2). 361–369. 20 indexed citations
8.
Grande, Carlos, Sonia Candamio, María José Villanueva, et al.. (2013). Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer. Journal of Geriatric Oncology. 4(2). 114–121. 11 indexed citations
9.
Barbazán, Jorge, María Vieito, Alicia Abalo, et al.. (2012). A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer. Journal of Cellular and Molecular Medicine. 16(10). 2342–2349. 19 indexed citations
10.
Barbazán, Jorge, Lorena Alonso‐Alconada, Laura Muinelo‐Romay, et al.. (2012). Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer. PLoS ONE. 7(7). e40476–e40476. 68 indexed citations
11.
Berciano, José, Jonathan Baets, Elena Gallardo, et al.. (2011). Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation. Journal of Neurology. 258(8). 1413–1421. 18 indexed citations
12.
Berciano, José, Elena Gallardo, José L. Fernández‐Torre, Vicente González‐Quintanilla, & Jon Infante. (2011). Magnetic resonance imaging of lower limb musculature in acute motor axonal neuropathy. Journal of Neurology. 259(6). 1111–1116. 7 indexed citations
13.
Berciano, José, Elena Gallardo, Antonio Garcı́a, et al.. (2010). Clinical progression in Charcot–Marie-Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family. Journal of Neurology. 257(10). 1633–1641. 11 indexed citations
14.
Cueva, Juan, Marcos Mecías‐Calvo, Urbano Anido, et al.. (2010). Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study. Investigational New Drugs. 30(2). 688–694. 7 indexed citations
15.
Navarro, Alfons, Tania Díaz, Elena Gallardo, et al.. (2010). Prognostic implications of miR‐16 expression levels in resected non‐small‐cell lung cancer. Journal of Surgical Oncology. 103(5). 411–415. 54 indexed citations
16.
Gallardo, Elena, Antonio Garcı́a, César Ramón, et al.. (2009). Charcot–Marie–Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family. Journal of Neurology. 256(12). 2061–2071. 18 indexed citations
17.
Berciano, José, Antonio Garcı́a, Elena Gallardo, César Ramón, & Onofre Combarros. (2009). Phenotype and Clinical Evolution of Charcot-Marie-Tooth Disease Type 1A Duplication. Advances in experimental medicine and biology. 652. 183–200. 4 indexed citations
18.
Maurel, Joan, Cristina Nadal, Xabier García‐Albéniz, et al.. (2007). Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. International Journal of Cancer. 121(5). 1066–1071. 90 indexed citations
19.
20.
Gallardo, Elena, Antonio Garcı́a, Onofre Combarros, & José Berciano. (2005). Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain. 129(2). 426–437. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026